27 July 2007 -- Keele, UK: Cobra Biomanufacturing plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announced that it will carry out sterility testing for the Atmospheric, Oceanic and Planetary Physics department of Oxford University as part of a mission to send a probe to Mars. The mission, ExoMars, is coordinated by the European Space Agency (ESA) who must follow international standards for the cleanliness of a spacecraft travelling to a planet that may contain life, or past indicators of life.
